The study met its primary endpoint with the addition of mepolizumab to inhaled maintenance therapy, achieving a “statistically significant and clinically meaningful reduction” in the ...
The London-listed firm said adjusted operating profit fell to £11m, compared to £16.2m in the first six months of 2023, reflecting ongoing challenges in the consumer and independent content ...